Intracerebral hemorrhage in a young woman with arteriovenous malformation after taking diet control pills containing phenylpropanolamine: a case report.
Administration of phenylpropanolamine (PPA) is a rare cause of intracerebral hemorrhage. We present the case of a young female patient with arteriovenous malformation who suffered an intracerebral hemorrhage after ingestion of diet pills containing PPA. The literature on PPA-related intracerebral hemorrhage is also reviewed. This is the first report of PPA-associated intracerebral hemorrhage in a patient with pathology-proven arteriovenous malformation of the brain. Because intracerebral hemorrhage may develop as a side effect of PPA when patients take the manufacturer's recommended dose, especially in patients with vascular abnormalities, we conclude that this medicine should be prescribed carefully and patients should be closely monitored by experienced physicians. Furthermore, its use should be contraindicated in patients who have, or possibly have, a family history of vascular abnormalities.
Department of Emergency Medicine, Taichung Veterans General Hospital, Taiwan, ROC.
Y T
YT
Chung
D Z
DZ
Hung
C P
CP
Hsu
D Y
DY
Yang
T C
TC
Wu
D000328:Adult; D001067:Appetite Depressants / Q000009:adverse effects*; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D000075202:Contraindications; D005260:Female; D006801:Humans; D002538:Intracranial Arteriovenous Malformations / Q000150:complications* / Q000000981:diagnostic imaging / Q000473:pathology; D010665:Phenylpropanolamine / Q000009:adverse effects*; D014057:Tomography, X-Ray Computed
D001067:Appetite Depressants; D010665:Phenylpropanolamine